Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy
Hoth Therapeutics, Inc.
Hoth Therapeutics Inc. (HOTH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 243,921 | $395,152 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.67 | 25,000 | $16,750.00 | 58,131 | 2024-08-16 | Filing | |
| $0.39 | 10,000 | $3,900.00 | 828,259 | 2022-09-19 | Filing | |
| $0.40 | 10,000 | $4,000.00 | 818,259 | 2022-09-16 | Filing | |
| $199,998.00 | 35,714 | $7,142,728,572.00 | 1,735,714 | 2019-02-28 | Filing | |
| $675,000.00 | 1,700,000 | $1,147,500,000,000.00 | 1,700,000 | 2017-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.25 | 400,000 | $500,000.00 | 1,130,674 | 2020-05-26 | Filing | |
| $0.00 | 0 | $0.00 | 0 | 2020-05-26 | Filing | |
| $1.25 | 400,000 | $500,000.00 | 1,130,674 | 2020-05-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 214,009 | $346,694 | 0% | |
| 2. | 153,535 | $248,726 | 0% | |
| 3. | 94,665 | $153,357 | 0% | |
| 4. | 12,830 | $20,656 | 0% | |
| 5. | 10,608 | $17,185 | 0% |
News See All
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
10 Biotech Penny Stocks Redditors Love
The bull market around the biotech sector has cooled in recent weeks as interest rates rise and push investors towards safer havens.
5 Best Biotech Penny Stocks to Buy Now
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) is a Boston-based biopharma firm founded in 2018. It is placed fifth on our list of 10 best biotech penny stocks to buy now.
Is Hoth Therapeutics, Inc. (HOTH) A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...